Related Experiment Videos
Oncogenes, molecular biology and the head and neck surgeon
1Department of Otolaryngology, Toronto Hospital, Ontario, Canada.
Abstract:
Advances in the treatment of head and neck cancer in the last 15 years have been largely limited to those that impact on patient morbidity while patient mortality statistics remain static. The advent of new technologies in molecular biology and immunology may provide the head and neck oncologist with the tools to impact on patient survival. The head and neck surgeon of the future will be required to have a basic understanding of their potential applications and limitations.
Insights
Head and neck cancer treatments have improved patient morbidity but not survival rates. New molecular biology and immunology tools offer potential to improve patient survival in head and neck oncology.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Head and neck cancer treatment advances over 15 years have primarily reduced patient morbidity.
- Patient mortality statistics for head and neck cancer have remained largely static despite treatment improvements.
Purpose of the Study:
- To explore the potential impact of emerging molecular biology and immunology technologies on head and neck cancer patient survival.
- To highlight the evolving skill set required for future head and neck surgeons.
Main Methods:
- Review of recent advancements in molecular biology relevant to cancer treatment.
- Analysis of emerging immunotherapeutic strategies for oncological applications.
- Assessment of the potential clinical integration of these new technologies.
Main Results:
- Current treatment progress in head and neck cancer has not significantly reduced mortality.
- Novel molecular and immunological approaches present promising avenues for improving patient survival.
- The integration of these technologies necessitates a foundational understanding for surgical oncologists.
Conclusions:
- Significant improvements in head and neck cancer patient survival are anticipated with the adoption of advanced molecular and immunological therapies.
- Future head and neck surgeons must possess a working knowledge of these cutting-edge technologies to effectively treat patients and improve outcomes.